MedTrace Logo

Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)

NCT01278485 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 726

Last updated 2015-07-28

Study results available
· View outcomes & findings →

Summary

This is a multicenter, observational, retrospective and cross-sectional study to be conducted in a cohort of consecutively selected participants with type 2 diabetes mellitus (T2DM) who have been treated with sulphonylurea (SU) monotherapy or SU + metformin (MF) combination therapy by their cardiologist, nephrologist, or family practice doctor for at least 6 months prior to study enrollment.

The purpose of the study is to assess treatment patterns, goal attainment rates, long-term diabetes complication rates, and frequency and severity of hypoglycemic episodes among T2DM participants treated in cardiology, nephrology and family practice settings.

Conditions

Interventions

DRUG

Sulphonylurea

SU administered according to usual practice.

DRUG

Metformn

Metformin administered according to usual practice.

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Merck Sharp & Dohme LLC

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-06-30
Completion
2012-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01278485 on ClinicalTrials.gov